Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Pharmacogenetic of Salbutamol in Pediatric Asthma Crisis
Clinical trial update indicating the pharmacogenetic study of Salbutamol in pediatric asthma crisis has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy [Phase 3]
Phase 3 randomized trial comparing Respimat Budesonide with Turbohaler Budesonide in symptomatic adult asthma patients on inhaled corticoste…
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma [Phase 3]
A Phase 3 trial evaluating the effect of fenoterol metered-dose inhaler on beta-receptor populations on lymphocytes in patients with asthma …
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom [Phase 4]
A Phase 4 trial evaluating the pharmacological effect of lysozyme for chronic obstructive pulmonary disease and asthma has completed. The st…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers [Phase 1, Phase 2]
A PK study of an epinephrine inhalation aerosol in healthy volunteers was completed, reporting pharmacokinetic data for potential asthma the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of Berodual inhaled via Respimat compared with a metered-dose inhaler in pediatric asthma…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients [Phase 3]
Phase 3 trial comparing Berodual Respimat to Berodual MDI in asthma patients has completed, evaluating safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition [Phase 3]
Phase 3 trial comparing Berodual Respimat with the Berodual MA Inhaler in patients with asthma, chronic obstructive pulmonary disease, or mi…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED) [Phase 2, Phase 3]
Completed Phase 2/3 trial evaluating the efficacy and long-term safety of a ragweed pollen sublingual tablet in adults with ragweed-induced …
-
CLINICAL_TRIALS research · 2014-07-14Clinical Trial Update: Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma [Phase 4]
Phase 4 clinical trial update examining the effects of montelukast on cough variant asthma; current status is not reported.
-
CLINICAL_TRIALS research · 2014-07-11Clinical Trial Update: A Long-term Study of Ba253BINEB in Patients With Bronchial Asthma [Phase 3]
A long-term Phase 3 trial evaluating Ba253BINEB in patients with asthma has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Determining the Optimal Adenosine Provocation Test [NA]
A completed clinical trial evaluating how to determine the optimal adenosine provocation test for asthma.
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Safety and Efficacy of YHD001 in Asthma [Phase 2]
Phase 2 study assessing safety and efficacy of YHD001 in asthma has been completed.
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities [Phase 3]
Phase 3 clinical trial update evaluating a collaborative care model to improve blood pressure control and reduce racial disparities in treat…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm [Phase 4]
A Phase 4 trial comparing Combivent to salbutamol in asthma patients with methacholine-induced bronchospasm has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Special Drug Use Investigation for ADOAIR Metered-dose Inhaler (Pediatric)
A clinical trial update indicates completion of a pediatric special drug use investigation for the ADOAIR metered-dose inhaler for asthma.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis [Phase 3]
Phase 3 trial evaluating Combivent Aerosol and Spacer for adults with moderate to severe asthma crisis was terminated.
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Exhaled Levels of Nitric Oxide [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluated exhaled nitric oxide levels in participants with tetraplegia and asthma; results have been posted follo…
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma [Phase 3]
Phase 3 trial evaluating tiotropium delivered by Respimat inhaler (2.5 and 5 mcg once daily) versus placebo in adults with moderate to sever…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234) [Phase 2, Phase 3]
Clinical trial update reporting efficacy and long-term safety of a ragweed sublingual immunotherapy tablet (SCH 39641) in adults with ragwee…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: The Development of a Clinical Test to Assess the Inflammatory Phenotype of Asthma
This document reports on the completion of a clinical trial focused on developing a diagnostic test to assess the inflammatory phenotype of …
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Efficacy (Bronchoprotection) and Safety of Orally Inhaled BI 1744 CL in Patients With Intermittent Asthma [Phase 2]
Phase 2 trial evaluating the bronchoprotective efficacy and safety of orally inhaled BI 1744 CL in patients with intermittent asthma; result…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts [Phase 1]
Phase 1 safety study update of sublingual immunotherapy tablets containing house dust mite allergen extracts; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases [Phase 4]
Phase 4 clinical trial evaluating aspirin desensitization for aspirin-exacerbated respiratory disease has completed, assessing its effect on…
-
FDA approval · 2014-06-28FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for budesonide and formoterol fumarate dihydrate (AstraZeneca) to expand its approved indications fo…